婴幼儿毛细支气管炎的临床治疗进展  

Progress in the clinical treatment of bronchiolitis in infants and young children

作　　者：张旭[1] ZHANG Xu(Changchun University of Chinese Medicine,Jilin,Changchun 130000,China)

机构地区：[1]长春中医药大学,吉林长春130000

出　　处：《中国医药科学》2023年第4期60-63,共4页China Medicine And Pharmacy

摘　　要：毛细支气管炎是婴幼儿较常见的急性下呼吸道感染性疾病,多与呼吸道合胞病毒感染有关。喘息及肺部哮鸣音是其突出的临床表现,严重者可有呼吸窘迫、呼吸暂停或低氧血症等症状。近年来,毛细支气管炎作为严重危害婴幼儿生命健康的全球性疾病,其发病机制及预防治疗手段成为临床研究的重点。本研究主要对毛细支气管炎临床治疗方案进行综述,探讨对症治疗、抗感染治疗及免疫治疗对婴幼儿毛细支气管炎的有效性及安全性,为毛细支气管炎的治疗提供参考。Bronchiolitis is a relatively common acute lower respiratory tract infection disease in infants and young children,which is mostly related to respiratory syncytial virus infection.Asthma and pulmonary wheezing are the prominent clinical manifestations,and severe cases may have symptoms such as respiratory distress,apnea or hypoxemia.In recent years,bronchiolitis has been a global disease that seriously endangers the life and health of infants and young children,and its pathogenesis and prevention and treatment means have become the focus of its clinical researches.The clinical treatment schemes of bronchiolitis are mainly reviewed in this paper.The effectiveness and safety of symptomatic treatment,anti-infection treatment and immunotherapy in bronchiolitis in infants and young children are investigated,so as to provide reference for the treatment of bronchiolitis.

关 键 词：毛细支气管炎 治疗 婴幼儿 进展 

分 类 号：R272[医药卫生—中医儿科学]